Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging

Pulmonary infections caused by Pseudomonas aeruginosa (PA) represent the leading cause of pulmonary morbidity in adults with cystic fibrosis (CF). In addition to tobramycin, colistin, and aztreonam, levofloxacin has been approved in Europe to treat PA infections. Nevertheless, no lung deposition dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Carsten, Procaccianti, Claudio, Mignot, Benjamin, Sadafi, Hosein, Schwenck, Nicolas, Murgia, Xabier, Bianco, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708197/
https://www.ncbi.nlm.nih.gov/pubmed/34959333
http://dx.doi.org/10.3390/pharmaceutics13122051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708197/
https://www.ncbi.nlm.nih.gov/pubmed/34959333
http://dx.doi.org/10.3390/pharmaceutics13122051

Ejemplares similares